|
Volumn 27, Issue 4, 2013, Pages 235-242
|
The effect of bevacizumab versus ranibizumab in the treatment of corneal neovascularization: a preliminary study.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANGIOGENESIS INHIBITOR;
BEVACIZUMAB;
MONOCLONAL ANTIBODY;
RANIBIZUMAB;
ADULT;
AGED;
COMPARATIVE STUDY;
CONTROLLED STUDY;
CORNEAL NEOVASCULARIZATION;
FEMALE;
HUMAN;
MALE;
MIDDLE AGED;
PILOT STUDY;
PROSPECTIVE STUDY;
RANDOMIZED CONTROLLED TRIAL;
TREATMENT OUTCOME;
VERY ELDERLY;
YOUNG ADULT;
ADULT;
AGED;
AGED, 80 AND OVER;
ANGIOGENESIS INHIBITORS;
ANTIBODIES, MONOCLONAL, HUMANIZED;
CORNEAL NEOVASCULARIZATION;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
PILOT PROJECTS;
PROSPECTIVE STUDIES;
TREATMENT OUTCOME;
YOUNG ADULT;
|
EID: 84896143615
PISSN: 10118942
EISSN: None
Source Type: Journal
DOI: 10.3341/kjo.2013.27.4.235 Document Type: Article |
Times cited : (24)
|
References (0)
|